Victor H. Van Cleave

833 total citations
18 papers, 701 citations indexed

About

Victor H. Van Cleave is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Victor H. Van Cleave has authored 18 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Victor H. Van Cleave's work include T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (7 papers). Victor H. Van Cleave is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immune Cell Function and Interaction (7 papers). Victor H. Van Cleave collaborates with scholars based in United States and United Kingdom. Victor H. Van Cleave's co-authors include Dennis W. Metzger, C.A. Hunter, Jack S. Remington, Carlos S. Subauste, Laura A. Vogel, John T. Collins, Wesley A. Dunnick, Clayton W. Naeve, Roberta Raeder and Louise C. Showe and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Victor H. Van Cleave

18 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor H. Van Cleave United States 10 436 247 223 95 57 18 701
Kenneth Munroe United States 7 251 0.6× 84 0.3× 109 0.5× 139 1.5× 30 0.5× 11 482
P O Leinikki United States 11 110 0.3× 239 1.0× 181 0.8× 75 0.8× 29 0.5× 13 480
Shivanthi P. Manickasingham United Kingdom 8 862 2.0× 77 0.3× 63 0.3× 116 1.2× 39 0.7× 10 973
Rachael Racine United States 12 444 1.0× 132 0.5× 83 0.4× 69 0.7× 44 0.8× 14 724
Mary K. Wloch United States 14 336 0.8× 497 2.0× 76 0.3× 185 1.9× 44 0.8× 22 856
Eckehart Kölsch Germany 13 421 1.0× 99 0.4× 40 0.2× 130 1.4× 55 1.0× 39 696
Ronald B. Smeltz United States 13 383 0.9× 98 0.4× 66 0.3× 102 1.1× 48 0.8× 19 567
Stephanie Könen‐Waisman Germany 13 311 0.7× 500 2.0× 580 2.6× 181 1.9× 78 1.4× 13 940
Kimberly M. Cirelli United States 8 315 0.7× 264 1.1× 357 1.6× 326 3.4× 104 1.8× 8 851
Christine Mazingue France 12 157 0.4× 55 0.2× 190 0.9× 91 1.0× 104 1.8× 24 490

Countries citing papers authored by Victor H. Van Cleave

Since Specialization
Citations

This map shows the geographic impact of Victor H. Van Cleave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor H. Van Cleave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor H. Van Cleave more than expected).

Fields of papers citing papers by Victor H. Van Cleave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor H. Van Cleave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor H. Van Cleave. The network helps show where Victor H. Van Cleave may publish in the future.

Co-authorship network of co-authors of Victor H. Van Cleave

This figure shows the co-authorship network connecting the top 25 collaborators of Victor H. Van Cleave. A scholar is included among the top collaborators of Victor H. Van Cleave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor H. Van Cleave. Victor H. Van Cleave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cotreau, Monette, Kevin Dykstra, Judy Oestreicher, et al.. (2005). A Single Administration of Recombinant Human Interleukin‐12 Is Associated With Increased Expression Levels of Interferon‐gamma and Signal Transducer and Activator of Transcription in Healthy Subjects. The Journal of Clinical Pharmacology. 45(6). 649–658. 5 indexed citations
2.
Cleave, Victor H. Van. (2003). Vailidation of immunoassays for anti-drug antibodies.. PubMed. 112. 107–12. 3 indexed citations
3.
Rouse, Jason C., et al.. (2001). Identification of human serum interferants in the recombinant P-selectin glycoprotein ligand-1 clinical ELISA using MALDI MS and RP-HPLC. Journal of Immunological Methods. 255(1-2). 41–56. 2 indexed citations
4.
Cleave, Victor H. Van, et al.. (1999). IL-12 is a potent neonatal vaccine adjuvant. European Journal of Immunology. 29(1). 256–264. 42 indexed citations
5.
Metzger, Dennis W., et al.. (1997). Interleukin‐12 acts as an adjuvant for humoral immunity through interferon‐γ‐dependent and ‐independent mechanisms. European Journal of Immunology. 27(8). 1958–1965. 76 indexed citations
6.
Metzger, Dennis W., et al.. (1996). Enhancement of Humoral Immunity by Interleukin‐12. Annals of the New York Academy of Sciences. 795(1). 100–115. 45 indexed citations
7.
Vogel, Laura A., et al.. (1996). Direct binding of IL-12 to human and murine B lymphocytes. International Immunology. 8(12). 1955–1962. 55 indexed citations
8.
Vogel, Laura A., et al.. (1996). Inhibition of murine B1 lymphocytes by interleukin‐12. European Journal of Immunology. 26(1). 219–223. 31 indexed citations
9.
Metzger, Dennis W., et al.. (1995). The effects of IL12 on B-cell subset function. Research in Immunology. 146(7-8). 499–505. 19 indexed citations
10.
Metzger, Dennis W., et al.. (1995). Protection of Mice from Group A Streptococcal Skin Infection by Interleukin-12. The Journal of Infectious Diseases. 171(6). 1643–1645. 34 indexed citations
11.
Vogel, Laura A., et al.. (1995). Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme. International Immunology. 7(9). 1519–1528. 61 indexed citations
12.
Hunter, C.A., Carlos S. Subauste, Victor H. Van Cleave, & Jack S. Remington. (1994). Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infection and Immunity. 62(7). 2818–2824. 288 indexed citations
13.
Metzger, Dennis W., et al.. (1992). Preparative Isolation of Murine CD5 B Cells by Panning and Magnetic Beadsa. Annals of the New York Academy of Sciences. 651(1). 75–77. 3 indexed citations
14.
Metzger, Dennis W., Clayton W. Naeve, & Victor H. Van Cleave. (1989). Epitope Mimicry by Anti-Idiotype Sequences in Reverse Orientation. PubMed. 251. 187–190. 1 indexed citations
15.
Cleave, Victor H. Van, Clayton W. Naeve, & Dennis W. Metzger. (1988). Do antibodies recognize amino acid side chains of protein antigens independently of the carbon backbone?. The Journal of Experimental Medicine. 167(6). 1841–1848. 25 indexed citations
16.
Metzger, Dennis W., Victor A. Fried, & Victor H. Van Cleave. (1987). In vivo activation of quiescent B cells by anti-immunoglobulin. I. Induction of latent VH allotype production in adult rabbits by treatment with heterologous antibodies or antibody fragments.. The Journal of Immunology. 138(9). 2982–2987. 3 indexed citations
17.
Cleave, Victor H. Van, et al.. (1986). Mouse monoclonal antibodies induced by anti‐allotype antibody display internal images of the rabbit VHa1 allotype: Direct visualization by immunoelectron microscopy. European Journal of Immunology. 16(6). 701–707. 6 indexed citations
18.
Cleave, Victor H. Van & Dennis W. Metzger. (1986). Heating of immunoglobulins for immunoblot analysis destroys variable region antigenicity. Journal of Immunological Methods. 93(2). 237–240. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Munroe Breakdown of academic impact, for papers by P O Leinikki Breakdown of academic impact, for papers by Shivanthi P. Manickasingham Breakdown of academic impact, for papers by Rachael Racine Breakdown of academic impact, for papers by Mary K. Wloch Breakdown of academic impact, for papers by Eckehart Kölsch Breakdown of academic impact, for papers by Ronald B. Smeltz Breakdown of academic impact, for papers by Stephanie Könen‐Waisman Breakdown of academic impact, for papers by Kimberly M. Cirelli Breakdown of academic impact, for papers by Christine Mazingue
Rankless by CCL
2026